The Identification of Immunological Biomarkers in Kidney Cancers

The Identification of Immunological Biomarkers in Kidney Cancers

The recent approval of several agents have revolutionized the scenario of therapeutic management of metastatic renal cell carcinoma (RCC) allowing us to reach important clinical end points with extended patients' survival. Actually, every new drug approved has represented an important step forw...

Full description

Bibliographic Details
Main Authors: Antonio Lopez-Beltran, Vanessa Henriques, Alessia Cimadamore, Matteo Santoni, Liang Cheng, Thomas Gevaert, Ana Blanca, Francesco Massari, Marina Scarpelli, Rodolfo Montironi
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-11-01
Series:Frontiers in Oncology
Subjects:
renal cell carcinoma
PD-L1
immunotherapy
RCC subtypes
immunological biomarker
predictive biomarker
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2018.00456/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2018.00456/full

Similar Items